If you’re researching Monogram Orthopedics stock, the most important thing to know is that the company is no longer a standalone, publicly traded investment. Monogram Orthopedics changed its name to Monogram Technologies Inc., traded on the NASDAQ exchange under the ticker symbol MGRM, and was acquired by Zimmer Biomet in a deal completed on October 7, 2025. With the acquisition complete, Monogram shares ceased trading on NASDAQ.
Below you’ll find what the company did, how its corporate identity changed over time, what the Zimmer Biomet acquisition meant for shareholders, and what the stock’s final market data looked like before it left the public markets.
What Happened to Monogram Orthopedics Stock?
Monogram Orthopedics drew investor interest as an innovative player in the orthopedic medical device market, but the company’s run as a public stock has ended. On October 7, 2025, Zimmer Biomet announced that it had completed its acquisition of Monogram Technologies. According to the announcement, each outstanding share of Monogram common stock was converted into the right to receive $4.04 in cash and up to $12.37 in cash. With the acquisition complete, Monogram shares ceased trading on NASDAQ.
That means you can no longer buy Monogram Orthopedics or Monogram Technologies stock on a public exchange, and any search for a live MGRM quote will turn up historical data rather than an active listing.
Company Background: What Monogram Orthopedics Did
Monogram Orthopedics was a medical technology company specializing in advanced orthopedic solutions. Founded by experienced medical engineers and orthopedic specialists, the company focused on surgical technologies designed to improve precision and patient outcomes. Its portfolio centered on several areas:
- 3D-printed custom orthopedic implants and patient-specific surgical interventions
- Precision-engineered surgical instruments and minimally invasive surgical solutions
- Computer-assisted surgical navigation systems and patient-specific anatomical modeling technologies
That focus on personalized, technology-driven orthopedic surgery is what put the company on the radar of both medical professionals and investors — and it is also the business that Zimmer Biomet ultimately acquired.
From Monogram Orthopedics to Monogram Technologies
Many investors still search for the company under its original name, which can make the stock’s history confusing to trace. In a Form 10-Q filed with the U.S. Securities and Exchange Commission, the company disclosed that on May 15, 2024, it changed its name from Monogram Orthopedics Inc. to Monogram Technologies Inc. Financial sites such as Yahoo Finance and Investing.com tracked the company on NASDAQ under the ticker symbol MGRM. So if you see references to Monogram Orthopedics stock, Monogram Technologies stock, or MGRM, they all point to the same company.
The Zimmer Biomet Acquisition
The defining event for anyone who held or followed this stock is the Zimmer Biomet deal. In its completion announcement dated October 7, 2025, Zimmer Biomet stated that each outstanding share of Monogram common stock was converted into the right to receive $4.04 in cash and up to $12.37 in cash. The accompanying press release confirmed that, with the acquisition complete, Monogram shares ceased trading on NASDAQ.
In practical terms, former shareholders’ positions did not simply disappear: under the announced terms, each outstanding share was converted into the right to receive the cash consideration described above. For specifics on how that consideration applies to your own holdings, the completion announcements from Zimmer Biomet are the primary references.
MGRM’s Final Market Snapshot
Market data captured around the end of the stock’s listed life gives a sense of where MGRM finished. Robinhood’s market data showed Monogram Technologies trading at $6.00 with a market cap of $243.79 million and a price-to-earnings ratio of -11.17. Data from stockanalysis.com dated October 6, 2025 showed a 52-week range of $1.92 to $6.43.
Frequently Asked Questions
Who acquired Monogram Orthopedics?
Zimmer Biomet. The company announced the completed acquisition of Monogram Technologies — the renamed Monogram Orthopedics — on October 7, 2025.
Is Monogram Orthopedics stock still trading?
No. With the acquisition complete, Monogram shares ceased trading on NASDAQ, so there is no longer a live public listing for the company.
What did shareholders receive in the acquisition?
According to Zimmer Biomet’s completion announcement, each outstanding share of Monogram common stock was converted into the right to receive $4.04 in cash and up to $12.37 in cash.
What was Monogram’s ticker symbol?
Monogram Technologies traded on NASDAQ under the ticker MGRM. The company changed its name from Monogram Orthopedics Inc. to Monogram Technologies Inc. on May 15, 2024.
The Bottom Line
Monogram Orthopedics is a closed chapter for public-market investors. The company built its reputation on 3D-printed custom implants, precision surgical instruments, and computer-assisted surgical navigation, renamed itself Monogram Technologies, and was then acquired by Zimmer Biomet, with shares ceasing to trade on NASDAQ once the deal closed on October 7, 2025. If you held shares, the announced terms converted them into the right to receive cash consideration; if you were considering an investment, the opportunity to buy the stock on a public exchange no longer exists.
English